Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case seriesCaoilfhionn M Connolly, Julie J. Paik, Mayan Teles et al.|Annals of the Rheumatic Diseases|2021Cited by 49
Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal diseaseSarah Frey, Julie J. Paik, Teresa Po‐Yu Chiang et al.|The Lancet Rheumatology|2022Cited by 25
Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel DiseaseSarah Frey, William A. Werbel, Dorry L. Segev et al.|Clinical Gastroenterology and Hepatology|2022Cited by 23
Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccinationSarah Frey, Julie J. Paik, Caoilfhionn M Connolly et al.|The Lancet Rheumatology|2021Cited by 12
Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseasesCaoilfhionn M Connolly, Julie J. Paik, Teresa Po‐Yu Chiang et al.|The Lancet Rheumatology|2022Cited by 10